New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes-Reference-Cited by-同舟云学术

New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes

Published:2017-09-18 Issue:9 Volume:12 Page:e0184680
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Buonomo Oreste Claudio,Caredda Emanuele,Portarena Ilaria,Vanni Gianluca,Orlandi Augusto,Bagni Claudia,Petrella Giuseppe,Palombi Leonardo^ORCID,Orsaria Paolo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype;MC Cheang;Clin Cancer Res,2008

2. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma;TO Nielsen;Clin Cancer Res,2004

3. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer;DA Berry;JAMA,2006

4. Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?;EM Azzato;Br J Cancer,2009

5. Metastatic behavior of breast cancer subtypes;H Kennecke;J Clin Oncol,2010

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biogenic nanoparticles: pioneering a new era in breast cancer therapeutics—a comprehensive review;Discover Nano;2024-08-03

2. New Insight for Axillary De-Escalation in Breast Cancer Surgery: “SoFT Study” Retrospective Analysis;Current Oncology;2024-07-23

3. Whole-brain radiation therapy plus simultaneous integrated boost for brain metastases from breast cancers;PeerJ;2024-07-12

4. Shear Wave Elastography in Breast Cancer: Unveiling Correlations With Histopathological Grades and Subtypes;Cureus;2024-07-03

5. Circulating tumor cells with metastasis-initiating competence survive fluid shear stress during hematogenous dissemination through CXCR4-PI3K/AKT signaling;Cancer Letters;2024-05